- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05968469
The Effects of Aerobic Exercise in Patients With Ankylosing Spondylitis
The Effect of Aerobic Exercise Program on Disease Activity, Quality of Life, Spinal Mobility and Serum Calprotectin, Visfatin, Leptin,IL-33 Levels in Patients With Ankylosing Spondylitis: Ultrasonographic Study
Study Overview
Status
Intervention / Treatment
Detailed Description
Ankylosing spondylitis (AS) is a painful and progressive chronic inflammation of the axial skeleton, mainly affecting the vertebral and sacroiliac joints. The management of AS aims to improve and maintain spinal mobility and normal posture, alleviate symptoms, reduce functional limitations and minimise complications. Due to the characteristic features of the disease, recommended spinal mobility exercises and aerobic exercises focus on reducing symptoms, improving functional capacity and quality of life, and improving and maintaining spinal mobility. Calprotectin, visfatin, leptin can be evaluated as biomarkers in inflammatory rheumatic diseases as an alternative to acute phase proteins and may reflect disease activity.
This study was designed as a prospective randomised controlled trial. Participants will be randomized into 2 groups and the intervention group will be given aerobic exercise and stretching exercise, and the other group only stretching exercise. BASDAI, BASMI, BASFI, ASQOL, ASDAS-CRP, Chest Expansion, 6 Minute Walk Test and Borg Scale will be used as assessment parameters.
Calprotectin, Visfatin, Leptin, IL-33 serum levels will be analysed by ELISA kit with blood samples taken in the early morning at the beginning of treatment, at the end of treatment (4th week) and at the 12th week after the beginning of treatment.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Afyonkarahisar, Turkey, 03200
- Recruiting
- Afyonkarahisar Health Sciences University
-
Contact:
- Faruk Emre YULCU
- Phone Number: +905301840495
- Email: farukemreyulcu@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosed with ankylosing spondylitis according to 2009 ASAS diagnostic criteria,
- 20-60 years old, male and female gender,
- No change in anti-rheumatic drugs and dosage in the last 3 months
- Those who have not done regular physical activity in the last 3 months,
- Patients who do not have any orthopedic, neurological or mental illness that may affect exercise will be included in the study.
Exclusion Criteria:
- Active malignancy and/or history of malignancy in the last 5 years,
- Uncontrolled cardiopulmonary disease,
- Unstable angina pectoris, cardiac arrhythmias and myocardial infarction within the last 3 months
- Presence of pregnancy or those planning a pregnancy in the near future,
- History of major surgery (including joint surgery) within the last six months
- Use of assistive devices for ambulation or orthopaedic joint prosthesis
- Patients with total spinal ankyloses
- Patients with a history of syncope, exercise-induced arrhythmia
- Regular exercise in the last 3 months
- Patients with contracture of the knee joint that prevents cycling exercise
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: High Intensity Interval Training (HIIT) protocol
Patients who underwent cycling ergometry program including high-intensity interval (HIIT) in the cardiopulmonary rehabilitation unit and stretching exercises for the cervical, thoracic and lumbar regions under the guidance of a physiotherapist
|
A total of 20 sessions of high-intensity interval (HIIT) aerobic exercise program will be applied to the patients using a bicycle ergometer, five days a week and once a day for four weeks. And then, it was planned to perform stretching exercises for the cervical, thoracic and lumbar regions and posture exercises accompanied by a specialist physiotherapist. The patients will be evaluated by the physician for a total of 3 times at the beginning of the treatment, at the end of the treatment (4th week) and at the 12th week after the start of the treatment. All patients will be evaluated for the parameters in the patient evaluation form, and blood samples taken between 08:00 and 10:00 in the morning and Calprotectin, Visfatin, Leptin, IL-33 serum levels will be measured with the ELISA kit. |
Active Comparator: Exercise program only:
Patients undergoing cervical, thoracic and lumbar stretching exercises in the hospital with a physiotherapist
|
Stretching exercises for the cervical, thoracic and lumbar regions and posture exercises were planned to be performed with the expert physiotherapist. The patients will be evaluated by the physician for a total of 3 times at the beginning of the treatment, at the end of the treatment (4th week) and at the 12th week after the start of the treatment. All patients will be evaluated for the parameters in the patient evaluation form, and blood samples taken between 08:00 and 10:00 in the morning and Calprotectin, Visfatin, Leptin, IL-33 serum levels will be measured with the ELISA kit. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in BASDAI
Time Frame: Baseline, after 4 and 12 weeks
|
The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) consists of 6 questions about disease activity.
Each question is scored on a scale of 0 to 10. High scores means high disease activity.
It is a reliable and sensitive to changes index developed to assess disease activity and progression.
|
Baseline, after 4 and 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in BASMI
Time Frame: Baseline, after 4 and 12 weeks
|
The Bath Ankylosing Spondylitis Metrology Index (BASMI) is related to the spinal mobility of patients with ankylosing spondylitis.
It consists of 5 clinical measurements.
The total score of 5 measurements is obtained, the score range is between 0-10, a lower score means better spinal mobility.
|
Baseline, after 4 and 12 weeks
|
Change in BASFI
Time Frame: Baseline, after 4 and 12 weeks
|
The Bath Ankylosing Spondylitis Functional Index (BASFI) is a sensitive and reliable index developed for the determination and follow-up of functional status in patients with AS.
It consists of 10 questions evaluating the functions of the patients.
The final score is obtained by dividing the total score by 10 using the VAS in the range of 0-10 cm for each question.
A high score indicates poor function.
|
Baseline, after 4 and 12 weeks
|
Change in ASQOL
Time Frame: Baseline, after 4 and 12 weeks
|
The Ankylosing Spondylitis Quality of Life Questionnaire (ASQoL) is the most widely used questionnaire to assess quality of life in AS, and it is valid and reliable.
In this questionnaire consisting of eighteen questions, patients are asked to answer yes or no to each question.
The total score varies between 0-18.
High scores indicate serious deterioration in quality of life
|
Baseline, after 4 and 12 weeks
|
Change in ASDAS-CRP
Time Frame: Baseline, after 4 and 12 weeks
|
The Ankylosing Spondylitis Disease Activity Score-CRP (ASDAS-CRP) consists of four questions and the acute phase reactants CRP mg/L result.
ASDAS-CRP will be calculated together with the CRP result in the formula.
Mild disease activity <1.3 Moderate disease activity 1.3-2.1 High disease activity 2.1-3.5 Very high disease activity >3.5
|
Baseline, after 4 and 12 weeks
|
Change in Chest Expansion
Time Frame: Baseline, after 4 and 12 weeks
|
Chest expansion is determined by measuring the chest circumference following a deep inspiration and forced expiration.
The expansion of the chest circumference is recorded in centimetres.
|
Baseline, after 4 and 12 weeks
|
Change in 6 Minute Walk Test
Time Frame: Baseline, after 4 and 12 weeks
|
The 6 Minute Walk Test is a sub-maximal exercise test used to assess aerobic capacity and endurance.
The score of the test is the distance a patient walks in 6 minutes.
|
Baseline, after 4 and 12 weeks
|
Change in Borg Scale
Time Frame: Baseline, after 4 and 12 weeks
|
The Borg scale is a numerical expression of the verbal expression of exercise intensity in patients undergoing cycle ergometry.
It allows direct comparison of individuals.
6 to 20 are evaluated.
The Borg scale is a numerical expression of the verbal expression of exercise intensity in patients undergoing cycling ergometry.
It allows direct comparison of individuals.
6 to 20 are evaluated.
As the activity becomes more difficult for the patient, the values given increase.
|
Baseline, after 4 and 12 weeks
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Yurdakul OV, Rezvani A. Can ultrasound be an assessment tool for sagittal spine mobility and chest expansion in patients with ankylosing spondylitis? Medicine (Baltimore). 2018 Sep;97(39):e12609. doi: 10.1097/MD.0000000000012609.
- Jennings F, Oliveira HA, de Souza MC, Cruz Vda G, Natour J. Effects of Aerobic Training in Patients with Ankylosing Spondylitis. J Rheumatol. 2015 Dec;42(12):2347-53. doi: 10.3899/jrheum.150518. Epub 2015 Nov 1.
- Diaconu AD, Ceasovschih A, Sorodoc V, Pomirleanu C, Lionte C, Sorodoc L, Ancuta C. Practical Significance of Biomarkers in Axial Spondyloarthritis: Updates on Diagnosis, Disease Activity, and Prognosis. Int J Mol Sci. 2022 Sep 30;23(19):11561. doi: 10.3390/ijms231911561.
Helpful Links
- Can ultrasound be an assessment tool for sagittal spine mobility and chest expansion in patients with ankylosing spondylitis?
- Effects of Aerobic Training in Patients with Ankylosing Spondylitis
- Practical Significance of Biomarkers in Axial Spondyloarthritis: Updates on Diagnosis, Disease Activity, and Prognosis
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ASHIIT2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ankylosing Spondylitis
-
Shanghai Junshi Bioscience Co., Ltd.Sponsor GmbHRecruitingActive Ankylosing SpondylitisChina
-
AbbVieBoehringer IngelheimCompletedAnkylosing Spondylitis (AS)
-
Sun Yat-sen UniversityUnknownEarly Ankylosing Spondylitis
-
AbbVieCompletedAnkylosing Spondylitis (AS)United States, Australia, Belgium, Canada, Croatia, Czechia, Denmark, Finland, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Spain, Sweden, United Kingdom
-
AbbVieCompletedAnkylosing Spondylitis (AS)Taiwan
-
Tongji HospitalWuhan Central Hospital; Wuhan Hospital of Traditional Chinese MedicineRecruitingAnkylosing Spondylitis (AS)China
-
Chinese University of Hong KongCompletedAnkylosing Spondylitis(AS)China
-
Tianjin Hemay Pharmaceutical Co., LtdCompletedActive Ankylosing SpondylitisChina
-
Jiangsu vcare pharmaceutical technology co., LTDRecruitingActive Ankylosing SpondylitisChina
-
Ankara City Hospital BilkentRecruitingAxial Spondyloarthritis and Ankylosing SpondylitisTurkey
Clinical Trials on Aerobic exercises with cycling ergometry
-
Hamilton Health Sciences CorporationCompletedCritical Illness | Critical Illness Myopathy | Thoracic Surgery | Cardiac Disease | Critical Illness PolyneuropathyCanada
-
Cairo UniversityCompleted
-
McMaster UniversityCompleted
-
VA Office of Research and DevelopmentRecruiting
-
Istanbul Medipol University HospitalCompletedCognitive Function 1, SocialTurkey
-
Riphah International UniversityCompletedPolycystic Ovary SyndromePakistan
-
University Hospital, Clermont-FerrandONAPS : Observatoire National de l'Activité Physique et de la SédentaritéUnknownAdolescents (12 to 17 Years Old) | Obese (BMI>90th Percentile)France
-
Istanbul Medeniyet UniversityRecruiting
-
University Hospital, Clermont-FerrandUnknown
-
Riphah International UniversityCompleted